23 October 2018
Enterome signs global licensing, co-development and co-promotion agreement with Takeda for the treatment of Crohn’s disease
Enterome, a clinical-stage biotech company developing innovative therapies to treat microbiome-associated diseases with a focus on auto-immune disease and cancer, has entered...